Healthcare DIVE November 4, 2024
Elise Reuter

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups look to build on former director Jeff Shuren’s leadership.

Michelle Tarver, the new leader of the Food and Drug Administration’s medical device center, faces significant challenges ahead.

Tarver is taking over as director of the Center for Devices and Radiological Health as the regulator grapples with questions around artificial intelligence in medical devices, racial bias in pulse oximeters, concerns about the recall process after Philips pulled millions of respiratory machines, and scrutiny of its former leader’s potential conflicts of interest.

Patient advocates, who have called for stronger device standards and faster, more transparent recalls, see an opportunity for change with a new director. Meanwhile,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices
FDA approves new CAR-T competitor to Gilead’s Tecartus
Vinod Khosla pleads with Elon Musk after Trump’s win, begging for better regulation of the FDA rather than ‘RFK kooky science’
How the US Election May Affect the FDA Regulation of Life Sciences Products - Key Areas to Watch
What Trump and Robert F. Kennedy Jr. might do to undermine vaccines — and what they likely can’t
RFK Jr. is expected to join Trump’s government after warning the ‘FDA’s war on public health is about to end,’ telling all employees to ‘pack your bags’

Share This Article